JHC
IMUX icon

Jones Hill Capital’s Immunic IMUX Stock Holding History

Jones Hill Capital’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.3M Buy
+539,814
New +$6.66M 1.76% 17

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Jones Hill Capital's IMUX Position: Q2 2026 in Review

Jones Hill Capital opened a new position in Immunic (IMUX) in Q2 2026: 539,814 shares worth $8.3M. The stake represents 1.76% of the portfolio and ranks #17 among its holdings.

54 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Jones Hill Capital held 539,814 shares of Immunic worth $8.3M as of Q2 2026.
  • Immunic was a new Jones Hill Capital position in Q2 2026.
  • Immunic made up 1.76% of Jones Hill Capital's portfolio in Q2 2026, its #17 holding.
  • 54 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Jones Hill Capital's 13F filing for Q2 2026, filed 13 Aug 2026.